Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics

Retrovirology

Volumn 9, Issue , 2012, Pages

  van Manen, Daniëlle ^a,b   van 't Wout, Angélique B ^a,b   Schuitemaker, Hanneke ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CRUCELL HOLLAND BV   (Netherlands)

Author keywords

Genome wide association studies; HIV pathogenesis; HIV susceptibility; Host genetics; Single nucleotide polymorphisms

Indexed keywords

COHORT ANALYSIS; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PATHOGENESIS; PHARMACOGENOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CELL INTERACTION; VIRUS REPLICATION;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84865285596     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-70     Document Type: Review

References (57)

1. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997, 185:621-628. 10.1084/jem.185.4.621, 2196142, 9034141.
2. Koot M, Keet IPM, Vos AHV, De Goede REY, Roos MTL, Coutinho RA, Miedema F, Schellekens PTA, Tersmette M. Prognostic value of human immunodeficiency virus type 1 biological phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993, 118:681-688.
3. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995, 270:988-991. 10.1126/science.270.5238.988, 7481804.
4. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997, 277:959-965. 10.1126/science.277.5328.959, 9252328.
5. Ioannidis JPA, O'Brien TR, Rosenberg PS, Contopoulos-Ioannidis DG, Goedert JJ. Genetic effects on HIV disease progression. Nature Med 1998, 4:536. 10.1038/nm0598-536, 9585207.
6. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promotor mutation. Nature Med 1998, 4:350-353. 10.1038/nm0398-350, 9500612.
7. van Rij RP, De Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis 1998, 178:1806-1811. 10.1086/314522, 9815240.
8. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998, 279:389-393. 10.1126/science.279.5349.389, 9430590.
9. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Stephan KT, Craig FE, O'Connell P, Tryon V, Clark RA, et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nature Med 1998, 4:786-793. 10.1038/nm0798-786, 9662369.
10. van Rij RP, Broersen S, Goudsmit J, Coutinho RA, Schuitemaker H. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection. AIDS 1998, 12:F85-F90. 10.1097/00002030-199809000-00002, 9662191.
11. Nakayama EE, Hoshino Y, Xin X, Liu H, Goto M, Watanabe N, Taguchi H, Hitani A, Kawana-Tachikawa A, Fukushima M, et al. Polymorphism in the Interleukin-4 promotor affects acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype. J Virol 2000, 74:5452-5459. 10.1128/JVI.74.12.5452-5459.2000, 112029, 10823849.
12. Kwa D, van Rij RP, Boeser-Nunnink B, Vingerhoed J, Schuitemaker H. Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using human immunodeficiency virus type 1 variants. AIDS 2003, 17:981-985. 10.1097/00002030-200305020-00006, 12700447.
13. Nakayama EE, Meyer L, Iwamoto A, Persoz A, Nagai Y, Rouzioux C, Delfraissy JF, Debre P, McIlroy D, Theodorou I, et al. Protective Effect of Interleukin-4-589T Polymorphism on Human Immunodeficiency Virus Type 1 Disease Progression: Relationship with Virus Load. J Infect Dis 2002, 185:1183-1186. 10.1086/339825, 11930331.
14. Wichukchinda N, Nakayama EE, Rojanawiwat A, Pathipvanich P, Auwanit W, Vongsheree S, Ariyoshi K, Sawanpanyalert P, Shioda T. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females. AIDS 2006, 20:189-196. 10.1097/01.aids.0000199830.64735.6f, 16511411.
15. Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P, Miedema F, Kootstra N, Schuitemaker H. Viral Replication Capacity as a Correlate of HLA B57/B5801-Associated Nonprogressive HIV-1 Infection. J Immunol 2007, 179:3133-3143.
16. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. eProc Natl Acad Sci U S A 2000, 97:2709-2714.
17. Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Altfeld M, O'Brien SJ, et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005, 11:1290-1292. 10.1038/nm1333, 16288280.
18. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996, 273:1856-1862. 10.1126/science.273.5283.1856, 8791590.
19. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:367-377. 10.1016/S0092-8674(00)80110-5, 8756719.
20. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber C-M, Saragosti S, Lapouméroulie C, Cognaux J, Forceille C, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725. 10.1038/382722a0, 8751444.
21. Rappaport J, Cho YY, Hendel H, Schwartz EJ, Schachter F, Zagury JF. 32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes. Lancet 1997, 349:922-923. 10.1016/S0140-6736(05)62697-9, 9093257.
22. De Roda Husman AM, Koot M, Cornelissen M, Brouwer M, Broersen SM, Bakker M, Roos MTL, Prins M, De Wolf F, Coutinho RA, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997, 127:882-890.
23. Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, Macartney M, Mori J, Rickett G, Smith-Burchnell C, Napier C, et al. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother 2005, 49:4721-4732. 10.1128/AAC.49.11.4721-4732.2005, 1280117, 16251317.
24. International Human Genome Sequencing Consortium Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945. 10.1038/nature03001, 15496913, International Human Genome Sequencing Consortium.
25. International HapMap Consortium The International HapMap Project. Nature 2003, 426:789-796. 10.1038/nature02168, 14685227, International HapMap Consortium.
26. Steemers FJ, Gunderson KL. Whole genome genotyping technologies on the BeadArray platform. Biotechnol J 2007, 2:41-49. 10.1002/biot.200600213, 17225249.
27. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317:944-947. 10.1126/science.1143767, 1991296, 17641165.
28. Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, O'Connor G, Ge D, Fellay J, Martin JN, et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 2009, 41:1290-1294. 10.1038/ng.486, 2887091, 19935663.
29. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, Bass SE, Martin MP, Hunt P, Deeks SG, Telenti A, et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011, 472:495-498. 10.1038/nature09914, 3084326, 21499264.
30. Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, et al. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS One 2008, 3:e3636. 10.1371/journal.pone.0003636, 2574440, 18982067.
31. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, Lambotte O, Avettand-Fenoel V, Le Clerc S, de Senneville LD, et al. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS One 2008, 3:e3907. 10.1371/journal.pone.0003907, 2603319, 19107206.
32. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, Labib T, Taing L, Sladek R, Deveau C, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009, 199:419-426. 10.1086/596067, 19115949.
33. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009, 5:e1000791. 10.1371/journal.pgen.1000791, 2791220, 20041166.
34. Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, Taing L, Delaneau O, Labib T, Sladek R, Deveau C, et al. Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis 2009, 200:1194-1201. 10.1086/605892, 19754311.
35. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557. 3235490, 21051598.
36. Joubert BR, Lange EM, Franceschini N, Mwapasa V, North KE, Meshnick SR. A whole genome association study of mother-to-child transmission of HIV in Malawi. Genome Med 2010, 2:17. 10.1186/gm138, 2873795, 20487506.
37. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, et al. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 2010, 201:618-626. 10.1086/649842, 2928718, 20064070.
38. Pelak K, Goldstein DB, Walley NM, Fellay J, Ge D, Shianna KV, Gumbs C, Gao X, Maia JM, Cronin KD, et al. Host Determinants of HIV-1 Control in African Americans. J Infect Dis 2010, 201:1141-1149. 10.1086/651382, 2838940, 20205591.
39. Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, Montes M, et al. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis 2010, 202:908-915. 10.1086/655782, 20704485.
40. Petrovski S, Fellay J, Shianna KV, Carpenetti N, Kumwenda J, Kamanga G, Kamwendo DD, Letvin NL, McMichael AJ, Haynes BF, et al. Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS 2011, 25:513-518. 10.1097/QAD.0b013e328343817b, 3150594, 21160409.
41. Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, Johnson RC, Sezgin E, Kessing B, Malasky M, Hendrickson SL, et al. Genome-wide association study implicates PARD3B-based AIDS restriction. J Infect Dis 2011, 203:1491-1502. 10.1093/infdis/jir046, 3080910, 21502085.
42. Bol SM, Moerland PD, Limou S, van Remmerden Y, Coulonges C, van Manen D, Herbeck JT, Fellay J, Sieberer M, Sietzema JG, et al. Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages. PLoS One 2011, 6:e17190. 10.1371/journal.pone.0017190, 3045405, 21364930.
43. van Manen D, Delaneau O, Kootstra NA, Boeser-Nunnink BD, Limou S, Bol SM, Burger JA, Zwinderman AH, Moerland PD, van 't Slot R, et al. Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course. PLoS One 2011, 6:e22208. 10.1371/journal.pone.0022208, 3141012, 21811574.
44. Chantarangsu S, Mushiroda T, Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W, Tantisiriwat W, Charoenyingwattana A, Sura T, Takahashi A, et al. Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash. Clin Infect Dis 2011, 53:341-348. 10.1093/cid/cir403, 21810746.
45. Lingappa JR, Petrovski S, Kahle E, Fellay J, Shianna K, McElrath MJ, Thomas KK, Baeten JM, Celum C, Wald A, et al. Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure. PLoS One 2011, 6:e28632. 10.1371/journal.pone.0028632, 3236203, 22174851.
46. Wang L, Zhu J, Shan S, Qin Y, Kong Y, Liu J, Wang Y, Xie Y. Repression of interferon-gamma expression in T cells by Prospero-related homeobox protein. Cell Res 2008, 18:911-920. 10.1038/cr.2008.275, 19160541.
47. Abraham S, Sawaya BE, Safak M, Batuman O, Khalili K, Amini S. Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology 2003, 309:196-202. 10.1016/S0042-6822(03)00112-0, 12758167.
48. van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, Van 't Wout AB, Schuitemaker H. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 2009, 23:19-28. 10.1097/QAD.0b013e32831db247, 19050382.
49. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367. 10.1073/pnas.0903103106, 2687147, 19474294.
50. Campbell MC, Tishkoff SA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 2008, 9:403-433. 10.1146/annurev.genom.9.081307.164258, 2953791, 18593304.
51. Shrestha S, Aissani B, Song W, Wilson CM, Kaslow RA, Tang J. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 2009, 23:673-677. 10.1097/QAD.0b013e328325d414, 2663898, 19276793.
52. Martin AM, Nolan D, Gaudieri S, Phillips E, Mallal S. Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity. Pharmacogenomics 2004, 5:643-655. 10.1517/14622416.5.6.643, 15335286.
53. Berns JS, Kasbekar N. Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists. Clin J Am Soc Nephrol 2006, 1:117-129.
54. Chantarangsu S, Mushiroda T, Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W, Tantisiriwat W, Charoenyingwattana A, Sura T, Chantratita W, et al. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients. Pharmacogenet Genomics 2009, 19:139-146. 10.1097/FPC.0b013e32831d0faf, 19104471.
55. McLaren P, Zagury JF, Fellay J, . The Intl HIV Acquisition Consortium Poster 295: Joining forces in HIV host genomics: The International HIV Acquisition Consortium. CROI 2012, . The Intl HIV Acquisition Consortium.
56. Fellay J, Shianna KV, Telenti A, Goldstein DB. Host genetics and HIV-1: the final phase?. PLoS Pathog 2010, 6:e1001033. 10.1371/journal.ppat.1001033, 2954832, 20976252.
57. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010, 363:166-176. 10.1056/NEJMra0905980, 20647212.